Whenever ‘materials’, such as cell lines, anti-bodies, model systems (plants/animals), databases or other substances, are transferred from one institution or company to another, arrangements on the use of such materials should be covered in a material transfer agreement (MTA) .
The materials should only be used for the purpose the materials were released for. Furthermore, the materials are and continue to be the property of the party providing them. They may not be given to other parties without the consent of the providing party. As a general rule, the party providing the materials also provides a contract template to the second party.
MTA process for IXA VU and VUmc
To properly asses an MTA request, IXA requires you to fill out an intake form. This form contains all relevant information for the legal department to develop/review the agreement. If you have received an MTA from an external party, please include the draft MTA together with IXA’s intake form.
For VUmc’s biobank we have a template you can fill in and use. This MTA can only be used in accordance with VUmc biobank policy and is only applicable for human samples and associated data. Click here to download the template.
For non-biobank MTA’s, please download and fill in the appropriate intake form and send with the received MTA (if applicable) to IXA.
Scientists are now able to view live molecular interactions as they would occur in the body, thanks to a unique partnership between AstraZeneca, LUMICKS and the University of Cambridge. The world’s first centre for dynamic single-molecule analysis has been established at the university’s Department of Biochemistry on Tennis Court Road to help accelerate drug discovery. […]News
VU onderzoeker Tamara Bouwman heeft donderdag 7 maart na een intensieve publiekscampagne voor de Medische Inspirator Prijs de tweede prijs van €50.000 ontvangen voor haar project ‘De online Vriendschapscursus’. Met de prijs gaat Bouwman in samenwerking met cliëntvertegenwoordiger Liesbeth Gaasbeek van de Gouden Dagen de online vriendschapscursus verder ontwikkelen. Uiteindelijk hopen ze de cursus daarmee […]News
The Dutch healthtech company Nico.lab prepares for an IPO in Australia after the company has previously collected 3 million euros from Australian investors. In addition, Nico.lab will enter the US market. Nico.lab is the result of a collaboration between Amsterdam UMC and health tech venture builder NLC. With years of intensive clinical research in the […]News